We have been saying it here for years: nutrition and inflammation are not parallel tracks in the diabetic foot. They are the same track. Chronic inflammation devours nutritional reserves. Nutritional deficiency fans the inflammatory flame. And the foot — sitting at the end of a long and compromised vascular tree — absorbs the consequences of both.
We have covered this intersection repeatedly on this blog. A 2025 study showed that larger wounds create greater nutritional deficits — and that most patients with DFUs do not meet dietary guidelines for wound healing. Earlier, clinical trial data pointed to vitamin D as a significant, inexpensive, and widely available adjunct in DFU treatment. And more recently, a review of the fat-soluble trio — vitamins A, D, and E — extended the conversation from wound healing to nerve health. We have also explored this from the microbial side, with data linking gut dysbiosis to DFU risk and the broader notion that probiotic and postbiotic delivery systems may serve as therapeutic platforms for chronic wound management.
Now, a new study from Wang and colleagues at Honghui Hospital, Xi’an Jiaotong University, takes a different and complementary tack. Instead of looking at a single nutrient or a single inflammatory marker, they asked: what if we combined them into one ratio?
The NPAR: A Single Number That Captures Two Converging Pathologies
The neutrophil percentage-to-albumin ratio (NPAR) is exactly what it sounds like: neutrophil percentage divided by serum albumin. Neutrophils are the most abundant white blood cell and the first responder in acute inflammation; their percentage rises when the immune system is in overdrive. Albumin is the principal circulating protein and a well-established marker of nutritional health — it drops when patients are malnourished, chronically inflamed, or both. The ratio captures both signals in a single, easily calculated number derived from routine labs. No exotic assay. No added cost.
In a retrospective analysis of 1,002 diabetic patients (251 with DFU, 751 without), the investigators found that higher NPAR was significantly associated with increased DFU risk. In the fully adjusted model, each 1-unit rise in NPAR corresponded to a 29% increase in the odds of DFU (OR 1.293, 95% CI: 1.212–1.378). Patients in the highest NPAR tertile had nearly four times the risk of DFU compared to the lowest tertile (OR 3.706, 95% CI: 2.267–6.058). These associations held across subgroups stratified by sex and age — including a striking sevenfold risk in males under 60 in the highest NPAR category.
From Biomarker to Bedside: The Nomogram
The team did not stop at association. Using LASSO regression followed by multivariate logistic regression, they identified eight risk-associated indicators — NPAR, age, sex, BMI, smoking, peripheral vascular disease, peripheral neuropathy, and hemoglobin — and built a nomogram for individualized DFU risk prediction. The model performed well: AUC of 0.892 in the training cohort and 0.877 in validation, with 80.8% sensitivity and 82.1% specificity at the optimal cutoff. Decision curve analysis confirmed net clinical benefit across a broad range of threshold probabilities.
This is the kind of translational work that matters in the real world. The components of this model — PVD, peripheral neuropathy, smoking status, hemoglobin, albumin — are things we already measure or should be measuring in every diabetic patient. Combining them into a structured risk score brings quantitative rigor to what many experienced clinicians do intuitively.
The Biological Logic
The biology underneath these numbers is well established and elegantly self-reinforcing. In the diabetic foot, neutrophils become chronically hyperactivated — delayed apoptosis, excessive reactive oxygen species production, exuberant neutrophil extracellular trap (NET) formation. These processes damage endothelial cells, fibroblasts, and epithelial cells at the wound site. Meanwhile, the chronic inflammatory state redirects hepatic protein synthesis toward acute-phase reactants like CRP and away from albumin — a molecular version of robbing Peter to pay Paul. The result is simultaneous immune dysregulation and nutritional depletion.
Lower albumin also means less antioxidant capacity, less oncotic pressure, more edema, worse wound healing. Lower hemoglobin means less oxygen delivery to already ischemic tissue. Malnutrition drives sarcopenia, which worsens foot deformity, which increases plantar pressure, which produces more ulcers. It is a vicious cycle, and NPAR sits at the nexus of its two most important arms.
Limitations and Next Steps
This is a single-center retrospective study from China, and the authors are appropriately measured about its limitations. The NPAR was measured at diagnosis, not prospectively before DFU onset. Residual confounding from unmeasured variables (diabetes duration, medications, nutritional supplementation) cannot be excluded. External validation in multi-center and multi-ethnic cohorts is needed before this model can be recommended for broad clinical adoption. The cut-off value of NPAR (16.9) may not generalize across populations with different baseline inflammatory and nutritional profiles.
But the direction of travel is right, and the clinical implications are immediate: check the albumin. Look at the neutrophil percentage. If a patient with diabetes has both values moving in the wrong direction, their feet are telling you something — even before the skin breaks down.
You are what you eat. And what you inflame.
Citation: Wang J, Zhang Y, Wang Q, Sun J, Jin Y, Zhao H. Establishment and evaluation of a novel tool based on inflammation-nutrition derived biomarkers for early diagnosis of diabetic foot ulcers. Front Immunol. 2026;17:1794011. DOI: 10.3389/fimmu.2026.1794011
#ActAgainstAmputation #DiabeticFoot #DFU #Nutrition #Inflammation #LimbPreservation #Biomarkers #WoundHealing #NPAR #ALPSLimb #Prevention #DiabetesCare
Leave a Reply